Nature Methods
- 4, 785 - 786 (2007)
doi:10.1038/nmeth1007-785
Proteomics from the clinical perspective: many hopes and much debateLaura Beretta
Laura Beretta is at the Molecular Diagnostics Program, Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA. lberetta@fhcrc.org
Mass spectrometry has been rapidly maturing as the core technology at the heart of proteomics. The application of these powerful methods to the study of human diseases and their translation to the clinic, however, has been beset with unique challenges.
MORE ARTICLES LIKE THIS These links to content published by NPG are automatically generated.
|
